Back to top
more

iShares Genomics Immunology and Healthcare ETF: (IDNA)

(Delayed Data from NYSE) As of May 7, 2024 04:00 PM ET

$23.92 USD

23.92
13,975

+0.07 (0.29%)

Volume: 13,975

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

NA

After-Market: $23.88 -0.04 (-0.17 %) 7:58 PM ET

ETF Quote Details

Previous Close 23.85
Open 23.90
Bid 22.54
Ask 25.22
Day Low-High 23.75-23.97
52wk Low-High 17.33-25.52
Volume 13,975
NAV (month end) 22.57
Premium (+)/Discount (-) (month end)+1.28

Zacks Premium Research for IDNA

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

 NA
ETF Risk

Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.

NA
ETF Snapshot

ETF Expense Ratio

Expense Ratio 0.47%
Dividend (Yield) $0.24 (1.01%)
Issuer BLACKROCK

Benchmark for IDNA

NYSE FACTSET GLBL GNM & IMUNO BIOPHRM ID

The NYSE FactSet Global Genomics and Immuno Biopharma Index comprises of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology, and bioengineering.

Fund Summary for IDNA

ISHARES GENOMICS IMMUNOLOGY & HLTCR ETF

The iShares Genomics Immunology and Healthcare ETF seeks to track the investment results of the NYSE FactSet Global Genomics and Immuno Biopharma Index.